The Pharmacology of Acute Lung Injury in Sepsis
Acute lung injury (ALI) secondary to sepsis is one of the leading causes of death in sepsis. As such, many pharmacologic and nonpharmacologic strategies have been employed to attenuate its course. Very few of these strategies have proven beneficial. In this paper, we discuss the epidemiology and pat...
Saved in:
Main Author: | Brian Michael Varisco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Advances in Pharmacological Sciences |
Online Access: | http://dx.doi.org/10.1155/2011/254619 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury
by: Fei Sun, et al.
Published: (2024-01-01) -
The injury effect of osteopontin in sepsis-associated lung injury
by: Qian Wang, et al.
Published: (2025-01-01) -
The Effects of Dexmedetomidine on Secondary Acute Lung and Kidney Injuries in the Rat Model of Intra-Abdominal Sepsis
by: Uğur Koca, et al.
Published: (2013-01-01) -
Plasma-derived extracellular vesicles prime alveolar macrophages for autophagy and ferroptosis in sepsis-induced acute lung injury
by: Rongzong Ye, et al.
Published: (2025-02-01) -
Biomarker Acute Kidney Injury (AKI) pada Sepsis
by: Dional Setiawan, et al.
Published: (2018-07-01)